Top compounds associated with response to TAAR5


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.07
mRNA lapatinib CCLE pan-cancer AAC -0.078 0.07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.057 0.07
mRNA CI-976 CTRPv2 pan-cancer AAC 0.068 0.07
mRNA MPS-1-IN-1 GDSC1000 pan-cancer AAC -0.056 0.07
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC -0.053 0.07
mRNA GDC-0449 FIMM pan-cancer AAC -0.3 0.08
mRNA IOX2 GDSC1000 pan-cancer AAC 0.058 0.08
mRNA CEP-701 FIMM pan-cancer AAC -0.21 0.08
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.08
Download CSV